PB Try Advances in Psychiatric Treatment Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (2001) 25: 277. doi: 10.1192/pb.25.7.277-c
© 2001 The Royal College of Psychiatrists
This Article
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKane, J. P.
Right arrow Articles by Akram, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by McKane, J. P.
Right arrow Articles by Akram, G.
Psychiatric Bulletin (2001) 25: 277
© 2001 The Royal College of Psychiatrists


correspondence

Hyoscine patches in clozapine-induced hypersalivation

J. P. McKane, Consultant Psychiatrist, Charlotte Hall, Senior House Officer and Gazala Akram, Clinical Pharmacist

Leverndale Hospital, 510 Crookston Road, Glasgow

Sir: Hypersalivation associated with clozapine can be a distressing and difficult to manage side-effect (Cree et al, Psychiatric Bulletin, 2001, 25, 114-116). In recent months we have used hyoscine hydrobromide patches in a group of patients with disabling hypersalivation. We had used the patches to treat severe hypersalivation in a patient on depot medication on the advice of a colleague working in ear, nose and throat medicine. This patient had gained some relief from atropine drops but could not tolerate the bitter taste. He had not been helped by oral anticholinergic medication and it was to our surprise that he responded dramatically to the use of the patches.

We have since used the patches on four patients with severe disabling, clozapine-induced hypersalivation (dosage 500-800 mg/day). These patients had obvious drooling that often required a change of clothing with marked soaking of their pillows each morning. A dramatic improvement has been noted in each case.

The patches are well tolerated. They are sited on bare skin behind the ear and release 1 mg of hyoscine over a 72-hour period. They have brought about a sustained improvement in our patients' quality of life. This small sample suggests that hyoscine patches are effective especially in those patients suffering severe hypersalivation. It is interesting to note that the patches proved effective in patients who had not responded to oral treatments, including oral hyoscine.




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
S. K. Praharaj, P. Verma, D. Roy, and A. Singh
Is clonidine useful for treatment of clozapine-induced sialorrhea?
J Psychopharmacol, July 1, 2005; 19(4): 426 - 428.
[Abstract] [PDF]


This Article
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKane, J. P.
Right arrow Articles by Akram, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by McKane, J. P.
Right arrow Articles by Akram, G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals